📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Fennec Pharmaceuticals

1.1 - Company Overview

Fennec Pharmaceuticals Logo

Fennec Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of a sodium thiosulfate treatment to prevent hearing loss in children undergoing chemotherapy; a small-stage biotechnology company.

Products and services

  • Sodium Thiosulfate: Pediatric-focused treatment engineered to prevent hearing loss in children undergoing chemotherapy using sodium thiosulfate compound

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Fennec Pharmaceuticals

Sareum Logo

Sareum

HQ: United Kingdom Website
  • Description: Provider of targeted small molecule therapeutics for cancer and autoimmune diseases, delivering drug candidates for licensing at pre-clinical or early clinical stages. Pipeline includes SDC-1801 and SDC-1802 (TYK2/JAK1 inhibitors) and SRA737 (clinical-stage, oral, selective Chk1 inhibitor).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Sareum company profile →
Therapeutic Solutions International Logo

Therapeutic Solutions International

HQ: United States Website
  • Description: Provider of biotechnology therapies and nutraceuticals, including JadiCell mesenchymal stem cell therapy for COVID-19 lung injury, COPD, and CTE; QuadraMune to enhance natural killer cell activity and immune support; StemVacs and StemVacs-V cancer immunotherapies; CampbellCell for psychiatric diseases; and FloraStilbene as an immunotherapy adjuvant.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Therapeutic Solutions International company profile →
Nuvation Bio Logo

Nuvation Bio

HQ: United States Website
  • Description: Provider of oncology-focused biopharmaceutical therapies addressing unmet needs, developing oral targeted candidates including Taletrectinib (CNS-active, selective next-generation ROS1 inhibitor for ROS1-positive NSCLC), Safusidenib (potent mIDH1 inhibitor for grades 2-3 IDH1-mutant glioma), NUV-868 (BD2-selective BET inhibitor targeting BRD4), and NUV-1511 (drug-drug conjugate candidate).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nuvation Bio company profile →
Amal Therapeutics Logo

Amal Therapeutics

HQ: Switzerland Website
  • Description: Provider of proprietary oncology immunisation technology and therapeutic cancer vaccines, built on its KISIMA platform that delivers multiple antigens in a single vaccine. Offerings include ATP128, a clinical-stage therapeutic vaccine targeting metastatic colorectal cancer, and collaboration opportunities in immuno-oncology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Amal Therapeutics company profile →
MetaStat Logo

MetaStat

HQ: United States Website
  • Description: Provider of diagnostic technologies and therapeutics for the early detection and treatment of systemic metastasis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MetaStat company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Fennec Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Fennec Pharmaceuticals

2.2 - Growth funds investing in similar companies to Fennec Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Fennec Pharmaceuticals

4.2 - Public trading comparable groups for Fennec Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Fennec Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Fennec Pharmaceuticals

What does Fennec Pharmaceuticals do?

Fennec Pharmaceuticals is a provider of a sodium thiosulfate treatment to prevent hearing loss in children undergoing chemotherapy; a small-stage biotechnology company.

Who are Fennec Pharmaceuticals's competitors?

Fennec Pharmaceuticals's competitors and similar companies include Sareum, Therapeutic Solutions International, Nuvation Bio, Amal Therapeutics, and MetaStat.

Where is Fennec Pharmaceuticals headquartered?

Fennec Pharmaceuticals is headquartered in United States.

How many employees does Fennec Pharmaceuticals have?

Fennec Pharmaceuticals has 1,000 employees 🔒.

When was Fennec Pharmaceuticals founded?

Fennec Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Fennec Pharmaceuticals in?

Fennec Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Fennec Pharmaceuticals

Who are the top strategic acquirers in Fennec Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Fennec Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Fennec Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Fennec Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Fennec Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Fennec Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Fennec Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Fennec Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Fennec Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Fennec Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Fennec Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Fennec Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Fennec Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Fennec Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Fennec Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Fennec Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Fennec Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Fennec Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Fennec Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Fennec Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Fennec Pharmaceuticals